Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Sona Nanotech Inc. (C:SONA)

Business Focus: Medical Equipment, Supplies & Distribution

Sector:  Healthcare Industry:  Medical Equipment, Supplies & Distribution
 
See Regulatory Filings on SEDAR
Company Contact
Address: Purdy's Wharf Tower 2
1969 Upper Water St Suite 2001
HALIFAX NS B3J 3R7
Tel: N/A
Website: https://www.sonanano.com
IR: See website
Key People
Daniel Whittaker
Chairman of the Board
Darren Rowles
President, Chief Executive Officer
Robert Randall
Chief Financial Officer, Corporate Secretary
Business Overview
Sona Nanotech Inc. is a nanotechnology life sciences company. The principal business is the development and application of its technology for use in multiplex diagnostic testing platforms. The Company offers a suite of products and services for multiple applications, including custom conjugation, lateral flow test development, lateral flow test production, point of care diagnostics, drug delivery, photo-thermal therapy and cell imaging. The Company's products include Lateral flow. Its Lateral flow is a technology and a paper-based diagnostic test used to confirm the presence or absence of a target analyte in a sample without the need for specialist lab equipment. Lateral flow tests are used in various sectors, which include animal and veterinary health, food and drink, environmental testing, agricultural testing, and drugs of abuse.
Financial Overview
For the six months ended 30 April 2021, SonaNanotech Inc revenues was not reported. Net loss increasedfrom C$1.2M to C$6.8M. Higher net loss reflects Share-basedcompensation increase from C$142K to C$5.3M (expense),Recovery of project expenses decrease of 94% to C$27K(income), Salaries and benefits increase from C$285K toC$664K (expense). Basic Earnings per Share excludingExtraordinary Items decreased from -C$0.02 to -C$0.11.
Employees: 11 as of Oct 31, 2020
Reporting Currency: Canadian Dollars
Enterprise value: $22.05M as of Apr 30, 2021
Annual revenue (TTM): $0.00M as of Apr 30, 2021
EBITDA (TTM): -$14.76M as of Apr 30, 2021
Net annual income (TTM): -$11.92M as of Apr 30, 2021
Free cash flow (TTM): -$5.42M as of Apr 30, 2021
Net Debt Last Fiscal Year: N/A
Shares outstanding: 64,255,728 as of Apr 30, 2021
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization